Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Testing Pradaxa vs acetylsalicylic acid for preventing recurrent stroke misses its goal: Boehringer Ingelheim
May 16, 2019 Off

Testing Pradaxa vs acetylsalicylic acid for preventing recurrent stroke misses its goal: Boehringer Ingelheim

By BusinessWire

Boehringer Ingelheim’s the trial did not meet its primary endpoint, which was to show aclinically significant difference between dabigatran etexilate and ASAon reducing the risk of a recurrent stroke among post-stroke patientswith ESUS.

Entrectinib shrank tumours  ORR in all children and adolescents: Roche study
May 16, 2019 Off

Entrectinib shrank tumours ORR in all children and adolescents: Roche study

By Dino Mustafić

Roche study showed entrectinib shrank tumours (objective response rate; ORR) in all children and adolescents who had NTRK, ROS1 or ALK fusion-positive solid tumours (11 of 11 patients), including two patients achieving a complete response.

Pharming Group net profit up for Q1 2019
May 16, 2019 Off

Pharming Group net profit up for Q1 2019

By Dino Mustafić

Revenues increased approximately 19.5% to €35.2 million, compared with €29.5 million during the same period last year.

4D pharma’s Chron’s treating Thetanix meets objective
May 16, 2019 Off

4D pharma’s Chron’s treating Thetanix meets objective

By Dino Mustafić

4D pharma’s study of Thetanix for treating Crohn’s disease has met primary objective, as it showed Thetanix was well tolerated with a good safety profile.

ChargePoint Technology boosts UK presence with new appointment
May 16, 2019 Off

ChargePoint Technology boosts UK presence with new appointment

By Dino Mustafić

Contained and sterile transfer solutions expert, ChargePoint Technology, has appointed Stephen Eastick as UK Sales Manager.

May 16, 2019 Off

Takeda and London School of Hygiene & Tropical Medicine Establish "Takeda Chair in Global Child Health"

By BusinessWire

The “Takeda Chair in Global Child Health” is the first Chair at the London School of Hygiene & Tropical Medicine…

May 16, 2019 Off

Immunocore to Present New Tebentafusp (IMCgp100) Data in Advanced Melanoma at Upcoming 2019 ASCO Annual Meeting

By BusinessWire

Biomarker research to provide deeper understanding of mechanism of action, relationship between efficacy and adverse events OXFORDSHIRE, England & CONSHOHOCKEN,…

May 16, 2019 Off

Intensity Therapeutics to Present Data on Safety, Tumor Regression and Immune Activation of INT230-6 at ASCO 2019

By BusinessWire

WESTPORT, Conn.–(BUSINESS WIRE)–Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through…

May 16, 2019 Off

Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-HBVS for the Treatment of Chronic Hepatitis B Virus

By BusinessWire

— Clinical Proof-of-Concept Data Expected in Fourth Quarter of 2019 — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company”…

May 16, 2019 Off

IMV to Present New Data at 2019 ASCO Annual Meeting From Its Phase 2 Clinical Trial Evaluating DPX-Survivac in Ovarian Cancer

By BusinessWire

Company to host conference call following ASCO presentation on June 2 to discuss updated clinical data DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV…

Posts pagination

Previous 1 … 3,186 3,187 3,188 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine